| Report ID |
6511 |
| Drug Identification Number |
01919431 |
| Brand name |
ENGERIX B INJ SUS 20MCG/ML |
| Common or Proper name |
Hepatitis B vaccine (recombinant) |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
HEPATITIS B SURFACE ANTIGEN |
| Strength(s) |
20MCG |
| Dosage form(s) |
SUSPENSION |
| Route of administration |
INTRAMUSCULAR |
| Packaging size |
1's |
| ATC code |
J07BC |
| ATC description |
VIRAL VACCINES |
| Reason for shortage |
Demand increase for the drug. |
| Anticipated start date |
|
| Actual start date |
2017-04-06 |
| Estimated end date |
|
| Actual end date |
2019-12-09 |
| Shortage status |
Resolved |
| Updated date |
2019-12-10 |
| Company comments |
|
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
